Hologic, Inc. agreed to acquire 46.3% stake in SuperSonic Imagine SA from Bpifrance Participations SA, Andera Partners, Auriga Partners, Mérieux Participations 3, SLP, managed by Mérieux Equity Partners SAS and FCP CDC PME Croissance, managed by Bpifrance Investissement for €16.3 million.

Hologic, Inc. (NasdaqGS:HOLX) agreed to acquire 46.3% stake in SuperSonic Imagine SA (ENXTPA:SSI) from Bpifrance Participations SA, Andera Partners, Auriga Partners, Mérieux Participations 3, SLP, managed by Mérieux Equity Partners SAS and FCP CDC PME Croissance, managed by Bpifrance Investissement for €16.3 million on June 19, 2019. Under the terms, Hologic will pay €1.5 per share for 10.8 million shares of SuperSonic Imagine. Post completion, the sellers will not hold any shares in SuperSonic Imagine.

Immediately after the completion of the acquisition, Hologic would file a proposed tender offer in cash followed, as the case may be, by a mandatory squeeze-out for SuperSonic's outstanding shares. In addition, Hologic, Inc. (NasdaqGS:HOLX) made a binding offer to acquire a 53.7% stake in SuperSonic Imagine SA (ENXTPA:SSI) for €18.9 million on June 19, 2019. Pursuant to the completion of both transactions, Hologic will own 100% stake in SuperSonic.

The transaction is subject to obtaining French regulatory clearance regarding foreign investments, a favorable opinion of the SuperSonic Imagine board of directors based on the fairness opinion issued by the independent expert appointed by SuperSonic Imagine in accordance with the French Financial Markets Authority General Regulation, and other conditions. A consultation process with SuperSonic Imagine's social and economic committee is also required. Henri Philippe of Accuracy acted as the independent expert for SuperSonic Imagine.